Blog & Commentary
Simmons Hanly Conroy’s support blog is a place for clients and families to find news, education, and inspirational stories about the following areas of litigation: mesothelioma and asbestos, dangerous drugs and devices, consumer protection and mass torts, personal injury and environmental litigation.
Blog
Avandia Revised Warning Not Adequate, Court Rules
A federal court has agreed with plaintiff’s counsel in a recent ruling that warnings about the dangers of Avandia, a drug used to help manage Type II Diabetes, may have been inadequate, according… Read More
“Standing” to Sue: Homeowners To Have Their Day in Court Against ‘Backdrop of National Housing Crisis’
Almost two years ago several homeowners filed lawsuits accusing eight major homebuilders of causing them serious financial injuries. These injuries came to light when the housing market crashed and these normal, responsible… Read More
Simmons Hanly Conroy’s Miles for Meso 5K Coming this Weekend
We’re having a busy week here at the firm getting ready for our annual Miles for Meso 5K race, which is happening this Saturday. This year we’ve increased the prize money for… Read More
ADAO to Give Online Screening of Asbestos Documentary, Breathtaking
Breathtaking, a documentary on the deadly consequences of asbestos exposure, tells the story of filmmaker Kathleen Mullen’s father who died of mesothelioma as a result of Canada’s asbestos mining industry. The Asbestos… Read More
Simmons Hanly Conroy Connects with Mesothelioma Community at MARF
Simmons Hanly Conroy employees, clients and other members of the mesothelioma community came together during the 8th Annual International Symposium on Malignant Mesothelioma, held last month in Washington D.C. Every year the… Read More
Can Hot Coffee Documentary Help Wash Away Tort Reform Assumptions?
Everyone knows about the woman who sued McDonald’s because her coffee was too hot, right? Over the years it has become the poster child for so-called “frivolous lawsuits” and the “greedy lawyers”… Read More
Justice Department Publishes Amounts Received From False Marking Settlements
False marking claims have been in the news over the past year, as most intellectual property attorneys may well know. That’s because these kinds of cases have been launched to the forefront… Read More
FDA to Review Popular Birth Control Pill Yaz
Women who take birth control know doing so comes with a risk of blood clots, especially if they’re a smoker over 35. However, two new studies by the British Medical Journal found that women… Read More
Health Risks Underestimated for Popular Smoking-Cessation Drug Chantix
A Pharmaceutical watch dog group has reported that the risks of smoking cessation drug Chantix (Varenicline) have been underestimated in the latest round of the Food & Drug Administration reporting. The Institute for… Read More
Avandia Pulled From Shelves Months After Dangers Known
The Food & Drug Administration announced last week that it will pull the diabetes drug Avandia and its sister medications Avandamet and Avandaryl from retail pharmacy shelves beginning in November. After Nov. 18, only certified… Read More
